Golimumab 100mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £19,431,320 of indicative cost of Golimumab 100mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 5.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Golimumab 100mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Golimumab 100mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £1,759,409 |
| Co.durham & Darlington Nhs Foundation Tr | £770,600 |
| Western Sussex Hospitals Nhs Found Trust | £640,895 |
| University Hospital Southampton Nhs Ft | £602,746 |
| Maidstone And Tunbridge Wells Nhs Trust | £570,702 |
| Hampshire Hospitals Nhs Foundation Trust | £566,124 |
| Luton & Dunstable Hospital Trust | £558,494 |
| Royal Devon & Exeter Nhs Foundation Trst | £469,990 |
| Guy's & St Thomas' Nhs Foundation Trust | £425,737 |
| Oxford University Hospitals Nhs Ft | £381,485 |
The primary-care picture
Golimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Golimumab medicine page.